
almost 4 years ago // Sponsored by Gilead Sciences
Visceral leishmaniasis impacts some of the lowest-income populations across the globe and is almost always fatal if left untreated. Gilead is committed to partnerships that aim to end VL and other neglected tropical diseases around the world.